- Corporate Officers - S
- Smither John W
Insider Trading History of Smither John W
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Smither John W since 2015.
This trader's CIK number is 1559583.
At the time of last reporting, Smither John W was the Officer of Genelux Corp. (stock ticker symbol GNLX).
Also see all insider trading activities at Genelux Corp.
Note that in the past
Smither John W also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Kythera Biopharmaceuticals Inc (KYTH) by Smither John W
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2015 | KYTH | 0 | $0 | 77,321 | $5,400,339 | 80,713 | $1,574,160 |
Yearly summary of insider trading at Arcutis Biotherapeutics, Inc. (ARQT) by Smither John W
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2021 | ARQT | 0 | $0 | 12,023 | $409,524 | 15,396 | $25,878 |
| 2020 | ARQT | 0 | $0 | 7,000 | $210,000 | 16,875 | $28,365 |
Yearly summary of insider trading at Genelux Corp (GNLX) by Smither John W
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2026 | GNLX | 0 | $0 | 24,000 | $69,792 | 0 | $0 |
| 2024 | GNLX | 6,250 | $0 | 0 | $0 | 0 | $0 |
| 2023 | GNLX | 0 | $0 | 900 | $18,702 | 0 | $0 |
Insider trading activities at 3 companies by Smither John W:
1. Kythera Biopharmaceuticals Inc (KYTH)
2. Arcutis Biotherapeutics, Inc. (ARQT)
3. Genelux Corp (GNLX)
Table 1. Insider trading of Kythera Biopharmaceuticals Inc (KYTH) by Smither John W
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2015-09-25 | KYTH | Option Ex | 14,017 | 4.84 | 67,842 |
| 2015-09-23 | KYTH | Option Ex | 26,918 | 17.86 | 480,755 |
| 2015-09-24 | KYTH | Option Ex | 26,917 | 35.76 | 962,551 |
| 2015-09-23 | KYTH | Sale | 26,918 | 74.90 | 2,016,158 |
| 2015-09-24 | KYTH | Sale | 26,917 | 74.90 | 2,016,083 |
| 2015-09-22 | KYTH | Sale | 5,591 | 74.90 | 418,765 |
| 2015-09-22 | KYTH | Option Ex | 5,591 | 8.22 | 45,958 |
| 2015-09-18 | KYTH | Sale | 1,054 | 74.95 | 78,997 |
| 2015-09-18 | KYTH | Option Ex | 1,054 | 8.22 | 8,663 |
| 2015-06-25 | KYTH | Sale | 4,600 | 75.50 | 347,300 |
| 2015-04-30 | KYTH | Sale | 2,041 | 45.49 | 92,845 |
| 2015-03-05 | KYTH | Sale | 4,200 | 48.33 | 202,986 |
| 2015-02-18 | KYTH | Sale | 1,000 | 42.00 | 42,000 |
| 2015-02-17 | KYTH | Sale | 1,000 | 40.00 | 40,000 |
| 2015-01-29 | KYTH | Sale | 1,000 | 38.00 | 38,000 |
| 2015-01-23 | KYTH | Sale | 3,000 | 35.73 | 107,205 |
| 2015-01-05 | KYTH | Option Ex | 6,216 | 1.35 | 8,391 |
Table 2. Insider trading of Arcutis Biotherapeutics, Inc. (ARQT) by Smither John W
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2021-03-10 | ARQT | Option Ex | 500 | 1.68 | 840 |
| 2021-03-10 | ARQT | Sale | 1,750 | 32.90 | 57,575 |
| 2021-03-04 | ARQT | Option Ex | 12,396 | 1.68 | 20,837 |
| 2021-03-01 | ARQT | Sale | 773 | 34.20 | 26,439 |
| 2021-02-10 | ARQT | Sale | 2,750 | 35.64 | 98,010 |
| 2021-02-10 | ARQT | Option Ex | 750 | 1.68 | 1,260 |
| 2021-02-01 | ARQT | Option Ex | 1,250 | 1.68 | 2,101 |
| 2021-02-01 | ARQT | Sale | 5,000 | 35.00 | 175,000 |
| 2021-01-19 | ARQT | Sale | 1,750 | 30.00 | 52,500 |
| 2021-01-19 | ARQT | Option Ex | 500 | 1.68 | 840 |
| 2020-12-14 | ARQT | Option Ex | 1,500 | 1.68 | 2,521 |
| 2020-12-14 | ARQT | Sale | 5,250 | 30.00 | 157,500 |
| 2020-09-29 | ARQT | Option Ex | 500 | 1.68 | 840 |
| 2020-09-29 | ARQT | Sale | 1,750 | 30.00 | 52,500 |
| 2020-06-11 | ARQT | Option Ex | 14,875 | 1.68 | 25,004 |
Table 3. Insider trading of Genelux Corp (GNLX) by Smither John W
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2026-07-01 | GNLX | Sale | 12,000 | 2.91 | 34,896 |
| 2026-07-01 | GNLX | Sale | 12,000 | 2.91 | 34,896 |
| 2024-05-29 | GNLX | Buy | 6,250 | .00 | 0 |
| 2023-09-13 | GNLX | Sale | 900 | 20.78 | 18,702 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Smither John W
(Officer of Genelux Corp at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.